COVID-19 and Light Chain Amyloidosis: Correspondence.
作者信息
Mungmunpuntipantip Rujittika, Wiwanitkit Viroj
机构信息
Private Academic Consultant, Bangkok Thailand.
Dr DY Patil University, Pune, India.
出版信息
Am J Med. 2022 Jun;135(6):e136. doi: 10.1016/j.amjmed.2022.02.004.
Abstract
摘要
相似文献
1
COVID-19 and Light Chain Amyloidosis: Correspondence.新型冠状病毒肺炎与轻链淀粉样变性：通信
Am J Med. 2022 Jun;135(6):e136. doi: 10.1016/j.amjmed.2022.02.004.
2
Comments on COVID-19 and AL Amyloidosis, the Missing Links.关于新型冠状病毒肺炎与轻链型淀粉样变性：缺失的环节之评论
Am J Med. 2022 Jun;135(6):e137-e138. doi: 10.1016/j.amjmed.2022.02.011.
3
[Anesthesia for a man with bullous amyloidosis as the first sign of advanced primary amyloidosis].
Rev Esp Anestesiol Reanim. 2010 Dec;57(10):671-2. doi: 10.1016/s0034-9356(10)70305-4.
4
Primary amyloidosis.原发性淀粉样变性
Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):178-9. doi: 10.4103/0378-6323.157454.
5
Mucocutaneous Xanthodermatosis as Initial Presentation of Immunoglobulin Light Chain Amyloidosis.皮肤黏膜黄瘤病作为免疫球蛋白轻链淀粉样变性的初始表现
Am J Med. 2022 Jun;135(6):724-727. doi: 10.1016/j.amjmed.2021.12.011. Epub 2022 Jan 23.
6
Systemic light-chain amyloidosis presenting with rapid progressive heart failure.以快速进展性心力衰竭为表现的系统性轻链淀粉样变性
Ther Adv Cardiovasc Dis. 2013 Aug;7(4):224-7. doi: 10.1177/1753944713493468.
7
[Cardiopathy caused by light-chain amyloidosis].[轻链淀粉样变性所致心肌病]
Arch Inst Cardiol Mex. 1986 Mar-Apr;56(2):177-88.
8
Modification of QRS pattern in a patient with AL amyloidosis.一名AL淀粉样变性患者QRS波型的改变
Int J Cardiol. 2013 Apr 5;164(2):e9-e12. doi: 10.1016/j.ijcard.2012.09.146. Epub 2012 Oct 9.
9
Light chain amyloidosis circa 2010: six prognostic markers and one sobering reality.
J Am Soc Echocardiogr. 2010 Jun;23(6):653-5. doi: 10.1016/j.echo.2010.04.008.
10
Cardiac Care of Patients with Cardiac Amyloidosis.心脏淀粉样变性患者的心脏护理。
Acta Haematol. 2020;143(4):343-351. doi: 10.1159/000506919. Epub 2020 May 14.
引用本文的文献
1
COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?新型冠状病毒肺炎感染与疫苗接种及其与淀粉样变性的关系：我们目前了解多少？
Vaccines (Basel). 2023 Jun 24;11(7):1139. doi: 10.3390/vaccines11071139.
本文引用的文献
1
COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury.COVID-19 与轻链淀粉样变性，雪上加霜。
Am J Med. 2022 Apr;135 Suppl 1:S49-S52. doi: 10.1016/j.amjmed.2022.01.005. Epub 2022 Jan 23.
2
COVID-19 Vaccination in Oncology Patients Receiving Chemotherapy.接受化疗的肿瘤患者的新冠病毒疫苗接种
Clin Oncol (R Coll Radiol). 2021 Oct;33(10):e467. doi: 10.1016/j.clon.2021.07.005. Epub 2021 Jul 9.
3
Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19.新冠疫苗接种后的预期粘度、高粘度与既往新冠病毒感染
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211020833. doi: 10.1177/10760296211020833.
4
Blood viscosity of COVID-19 patient: a preliminary report.新型冠状病毒肺炎患者的血液粘度：初步报告。
Am J Blood Res. 2021 Feb 15;11(1):93-95. eCollection 2021.
5
Plasma cell myeloma, hyperviscosity and amyloidosis associated with a serum IgG3 lambda and urinary excretion of two fragments related to the variable portion of lambda light chains.
Clin Immunol Immunopathol. 1981 Apr;19(1):55-66. doi: 10.1016/0090-1229(81)90047-7.
Zotero 插件